DK0880363T3 - Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger - Google Patents
Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkningerInfo
- Publication number
- DK0880363T3 DK0880363T3 DK97907545T DK97907545T DK0880363T3 DK 0880363 T3 DK0880363 T3 DK 0880363T3 DK 97907545 T DK97907545 T DK 97907545T DK 97907545 T DK97907545 T DK 97907545T DK 0880363 T3 DK0880363 T3 DK 0880363T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitor
- leukotriene
- cyclooxygenase
- combinations
- well
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60065596A | 1996-02-13 | 1996-02-13 | |
PCT/US1997/001421 WO1997029774A1 (fr) | 1996-02-13 | 1997-02-11 | Combinaisons a effets immunosuppresseurs comprenant un inhibiteur de cyclooxygenase-2 et un inhibiteur de leucotriene a4 hydrolase |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0880363T3 true DK0880363T3 (da) | 2003-01-20 |
Family
ID=24404526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97907545T DK0880363T3 (da) | 1996-02-13 | 1997-02-11 | Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger |
Country Status (11)
Country | Link |
---|---|
US (3) | US6407140B1 (fr) |
EP (1) | EP0880363B1 (fr) |
JP (1) | JP2001506574A (fr) |
AT (1) | ATE223732T1 (fr) |
AU (1) | AU1952597A (fr) |
CA (1) | CA2246336A1 (fr) |
DE (1) | DE69715382T2 (fr) |
DK (1) | DK0880363T3 (fr) |
ES (1) | ES2183140T3 (fr) |
PT (1) | PT880363E (fr) |
WO (1) | WO1997029774A1 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69709069T2 (de) * | 1996-02-13 | 2002-07-04 | Searle & Co | Zusammensetzungen mit immunosuppressiven wirkungen, welche 5-lipoxygenase-inhibitoren und cyclooxygenase-2-inhibitoren enthalten |
DK0880363T3 (da) * | 1996-02-13 | 2003-01-20 | Searle & Co | Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger |
SE9703693D0 (sv) * | 1997-10-10 | 1997-10-10 | Astra Pharma Prod | Novel combination |
PT1303265E (pt) * | 2000-07-20 | 2007-10-09 | Lauras As | ''utilização de inibidores da cox-2 como imuno-estimulantes, no tratamento do vih ou da sida'' |
GB0112348D0 (en) | 2001-05-19 | 2001-07-11 | Smithkline Beecham Plc | Compounds |
AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
CA2462000A1 (fr) | 2001-10-09 | 2003-04-17 | 3-Dimensional Pharmaceuticals, Inc. | Diphenyloxazoles substitues ; synthese et utilisation comme sondes a fluorescence |
US20040146503A1 (en) * | 2002-08-28 | 2004-07-29 | Tesi Raymond J. | Methods and compositions for inducing stable immune tolerance |
US7507531B2 (en) | 2002-10-17 | 2009-03-24 | Decode Genetics Chf. | Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction |
US7851486B2 (en) | 2002-10-17 | 2010-12-14 | Decode Genetics Ehf. | Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment |
MX2007013179A (es) * | 2005-04-22 | 2008-01-16 | Wyeth Corp | Formas cristalinas de clorhidrato de {[(2r)-7-(diclorofenil)-5- fluoro-2,3-dihidro-1-benzofurano-2-il]metil}amina. |
AT502258B1 (de) * | 2005-07-22 | 2007-09-15 | Univ Wien | Cox-i-inhibitorverbindungen |
NL2000351C2 (nl) | 2005-12-22 | 2007-09-11 | Pfizer Prod Inc | Estrogeen-modulatoren. |
ES2614090T3 (es) * | 2005-12-29 | 2017-05-29 | Celtaxsys, Inc. | Derivados de diamina como inhibidores de leucotrieno A4 hidrolasa |
PA8802501A1 (es) | 2007-10-31 | 2009-06-23 | Janssen Pharmaceutica Nv | Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno, hidrolasa |
WO2009126806A2 (fr) | 2008-04-11 | 2009-10-15 | Janssen Pharmaceutica Nv | Amines de thiazolopyridin-2-yloxy-phenyl et de thiazolopyrazin-2-yloxy-phenyl en tant que modulateurs de leukotriene a4 hydrolase |
EP2430019B1 (fr) | 2009-05-14 | 2013-09-18 | Janssen Pharmaceutica, N.V. | Composes comprenant deux restes hétéroaryle bicycliques en tant que modulateurs de leukotriene a4 hydrolase |
EP2545964A1 (fr) | 2011-07-13 | 2013-01-16 | Phenex Pharmaceuticals AG | Nouveaux composés se liant au fxr (nr1 h4) et modulant son activité |
AU2014249168B2 (en) | 2013-03-12 | 2018-07-12 | Celltaxis, Llc | Methods of inhibiting leukotriene A4 hydrolase |
MX2015011677A (es) | 2013-03-14 | 2016-07-08 | Celtaxsys Inc | Inhibidores de leucotrieno a4 hidrolasa. |
BR112015022227A2 (pt) | 2013-03-14 | 2017-07-18 | Celtaxsys Inc | inibidores de leucotrieno a4 hidrolase |
RU2678196C2 (ru) | 2013-03-14 | 2019-01-24 | Селтакссис, Инк. | Производные 2-фениламино-3-цианопиразоло[1,5-а]пиримидина, полезные в качестве ингибитора лейкотриен-a4-гидролазы |
EP3730487B1 (fr) | 2016-06-13 | 2022-04-27 | Gilead Sciences, Inc. | Dérivés d'azetidine en tant que modulateurs de fxr (nr1h4) |
CA2968836A1 (fr) | 2016-06-13 | 2017-12-13 | Gilead Sciences, Inc. | Composes modulant fxr (nr1h4) |
EP4122464B1 (fr) | 2017-03-28 | 2024-05-15 | Gilead Sciences, Inc. | Combinaisons thérapeutiques pour le traitement des maladies du foie |
EP3801559A4 (fr) | 2018-05-31 | 2022-03-02 | Celltaxis, LLC | Procédé de réduction d'exacerbations pulmonaires chez des patients atteints d'une maladie respiratoire |
EP4360632A2 (fr) | 2019-01-15 | 2024-05-01 | Gilead Sciences, Inc. | Composés modulateurs de fxr (nr1h4) |
AU2020225225B2 (en) | 2019-02-19 | 2022-12-22 | Gilead Sciences, Inc. | Solid forms of FXR agonists |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59196839A (ja) | 1983-04-21 | 1984-11-08 | Sankyo Co Ltd | フエニル酢酸誘導体 |
US4873259A (en) | 1987-06-10 | 1989-10-10 | Abbott Laboratories | Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
US5242940A (en) | 1987-05-29 | 1993-09-07 | Ortho Pharmaceutical Corporation | Pharmacologically active N-1 and C-5 heterocyclic pyrazoles and method for synthesizing the same |
WO1989001772A1 (fr) | 1987-09-03 | 1989-03-09 | University Of Georgia Research Foundation, Inc. | Composition de cyclosporine oculaire |
US5234950A (en) | 1988-12-23 | 1993-08-10 | Imperial Chemical Industries Plc | Tetrahydrofuran derivatives |
GB8927287D0 (en) | 1988-12-23 | 1990-01-31 | Ici Plc | Cyclic ether derivatives |
US5220059A (en) | 1990-04-19 | 1993-06-15 | Abbott Laboratories | Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids |
DE69122759T2 (de) | 1990-07-25 | 1997-05-15 | Abbott Lab | Acetylenderivate mit lipoxygenase inhibitorischer wirkung |
IE913655A1 (en) | 1990-11-06 | 1992-05-22 | Zeneca Ltd | Synergistic agents |
CA2099868C (fr) | 1991-01-31 | 2002-04-02 | Thomas Richard Belliotti | 4,6-di-tert-butyl-5-hydroxy-pyrimidines substituees |
GB9215921D0 (en) | 1992-07-27 | 1992-09-09 | Wellcome Found | Anti-inflammatory compounds |
US5354865A (en) | 1992-09-10 | 1994-10-11 | Abbott Laboratories | Phenylmethyl derivatives having lipoxygenase inhibitory activity |
US5288751A (en) | 1992-11-06 | 1994-02-22 | Abbott Laboratories | [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis |
US5604260A (en) | 1992-12-11 | 1997-02-18 | Merck Frosst Canada Inc. | 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
ATE160345T1 (de) | 1993-01-15 | 1997-12-15 | Searle & Co | 3,4-diarylthiophene und analoga davon, sowie deren verwendung als entzündungshemmende mittel |
US5409944A (en) | 1993-03-12 | 1995-04-25 | Merck Frosst Canada, Inc. | Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase |
AU6718494A (en) | 1993-05-13 | 1994-12-12 | Merck Frosst Canada Inc. | 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase |
US5380738A (en) | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5298521A (en) | 1993-08-30 | 1994-03-29 | Ortho Pharmaceutical Corporation | 1,5-diphenyl-3-pyrazolylalkyl-N-hydroxydithiocaramates, compositions and use |
US5344991A (en) | 1993-10-29 | 1994-09-06 | G.D. Searle & Co. | 1,2 diarylcyclopentenyl compounds for the treatment of inflammation |
ES2193609T3 (es) | 1993-11-30 | 2003-11-01 | Searle & Co | Pirazolil-bencenosulfonamidas sustituidas y su uso como inhibidores de la ciclooxigenasa ii. |
US5393790A (en) | 1994-02-10 | 1995-02-28 | G.D. Searle & Co. | Substituted spiro compounds for the treatment of inflammation |
US5486534A (en) * | 1994-07-21 | 1996-01-23 | G. D. Searle & Co. | 3,4-substituted pyrazoles for the treatment of inflammation |
US6136839A (en) | 1995-06-12 | 2000-10-24 | G. D. Searle & Co. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
US5700816A (en) * | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
PT880362E (pt) * | 1996-02-13 | 2005-10-31 | Searle & Co | Composicoes compreendendo um inibidor do cicloxigenase tipo 2 e um antagonista do receptor do leucotrieno b4 |
DK0880363T3 (da) * | 1996-02-13 | 2003-01-20 | Searle & Co | Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger |
-
1997
- 1997-02-11 DK DK97907545T patent/DK0880363T3/da active
- 1997-02-11 JP JP52935897A patent/JP2001506574A/ja not_active Ceased
- 1997-02-11 WO PCT/US1997/001421 patent/WO1997029774A1/fr active IP Right Grant
- 1997-02-11 AU AU19525/97A patent/AU1952597A/en not_active Abandoned
- 1997-02-11 DE DE69715382T patent/DE69715382T2/de not_active Expired - Fee Related
- 1997-02-11 ES ES97907545T patent/ES2183140T3/es not_active Expired - Lifetime
- 1997-02-11 AT AT97907545T patent/ATE223732T1/de not_active IP Right Cessation
- 1997-02-11 PT PT97907545T patent/PT880363E/pt unknown
- 1997-02-11 CA CA002246336A patent/CA2246336A1/fr not_active Abandoned
- 1997-02-11 EP EP97907545A patent/EP0880363B1/fr not_active Expired - Lifetime
-
2000
- 2000-01-21 US US09/489,311 patent/US6407140B1/en not_active Expired - Fee Related
-
2002
- 2002-05-02 US US10/137,231 patent/US20030004191A1/en not_active Abandoned
-
2004
- 2004-08-27 US US10/928,835 patent/US20050043355A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030004191A1 (en) | 2003-01-02 |
DE69715382D1 (de) | 2002-10-17 |
ES2183140T3 (es) | 2003-03-16 |
AU1952597A (en) | 1997-09-02 |
CA2246336A1 (fr) | 1997-08-21 |
DE69715382T2 (de) | 2003-04-30 |
US6407140B1 (en) | 2002-06-18 |
ATE223732T1 (de) | 2002-09-15 |
JP2001506574A (ja) | 2001-05-22 |
EP0880363A1 (fr) | 1998-12-02 |
EP0880363B1 (fr) | 2002-09-11 |
PT880363E (pt) | 2002-12-31 |
US20050043355A1 (en) | 2005-02-24 |
WO1997029774A1 (fr) | 1997-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0880363T3 (da) | Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger | |
WO2001084376A3 (fr) | Systeme pour repondre a des questions formulees en langage naturel | |
TR199701705T1 (xx) | Trigliserid ya�lar�n i�lenmesinde hareketsiz enzim ve kullan�m�. | |
DK1066052T3 (da) | Mesenchymstamceller til forebyggelse og behandling af immunreaktioner ved transplantationer | |
AU2821601A (en) | Multipotent neural stem cells from peripheral tissues and uses thereof | |
DE69737724D1 (de) | Genidentifikationsverfahren | |
WO2007062387A3 (fr) | Greffes capillaires a base de cheveux d'epilation | |
DE3865044D1 (de) | Mittelohr-prothese. | |
DE60042209D1 (de) | Enzymatische synthese von deoxyribonucleotiden | |
AR015837A1 (es) | Metodo de transformacion de plantas. | |
WO2001078653A3 (fr) | Traitement du rejet de greffe au moyen d'inhibiteurs de la fonction ccr2 | |
ES2183955T3 (es) | Uso de mananasas como agentes de control del cieno. | |
Lovejoy | Satanizing the American Indian | |
DE69626816D1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
ES2162427T3 (es) | Diluyente de esperma que comprende fosfocaseinato natural o beta-lactoglobulina, su procedimiento de preparacion y sus utilizaciones. | |
Reichard | Significance of aspiration in Navaho | |
Zalasiewicz | Buried treasure | |
SE9603335D0 (sv) | Leksak | |
Pollard | The speech of the Rastafarians of Jamaica, in the eastern Caribbean: the case of St. Lucia | |
Schuurman et al. | Interview: Madagascar’s rosewood stocks–which way to go? | |
Oancea | RECEPTION OF GENESIS 2, 2–3 IN THE ORTHODOX WORSHIP OF THE HOLY WEEK | |
Westerlund | Nyberg Oskarsson, Gunilla, Le mouvement pentecôtiste—une communauté alternative au sud du Burundi, 1935-1960 | |
Lei | A Contrastive Study of the Distinction of Idioms between Chinese and English Based on Kluckhohn, FR, & Strodtbeck, FL’s Value Orientations | |
Johnson | Most Secret and Confidential: Intelligence in the Age of Nelson: Maffeo, Steven E.: Annapolis: Naval Institute Press, 355 pp., Publication Date: June 2000 | |
McCandless | Singular Continuities: Tradition, Nostalgia, and Identity in Modern British Culture: Behlmer, George K. Fred M. Leventhal, eds.: Stanford: Stanford University Press, 277 pp., Publication Date: August 2000 |